Related Experiment Video
Updated: Jul 15, 2026
10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
[New Cardiac Glycosides from Digitalis lanata.]
1Institut für Pharmazeutische Biologie der Philipps-Universität Marburg/L., Bundesrepublik Deutschland.
Planta Medica
|October 1, 1983
Summary
Researchers isolated and identified three new cardenolides from Digitalis lanata leaves. These compounds, including novel glycosides, were structurally elucidated using spectroscopic methods.
Area of Science:
- Pharmacognosy
- Natural Product Chemistry
- Organic Chemistry
Context:
- Digitalis lanata (Woolly Foxglove) is a known source of cardiac glycosides.
- Cardenolides are a class of cardiac glycosides with significant pharmacological activity.
- Isolation and characterization of new natural products are crucial for drug discovery.
Purpose:
- To isolate and determine the chemical structures of unknown compounds from Digitalis lanata.
- To contribute to the understanding of the phytochemical profile of Digitalis lanata.
- To identify novel cardenolides with potential therapeutic applications.
Summary:
- Three previously unknown cardenolides were isolated from the leaves of Digitalis lanata.
- Their structures were elucidated using Thin Layer Chromatography (TLC) and various spectroscopic techniques.
- The identified compounds include Digoxigenin-3-O-beta-D-digitoxosido-beta-D-digitoxosido-beta-D-glucomethyloside, Digoxigenin-3-O-beta-D-digitoxosido-beta-D-glucomethyloside, and Diginatigenin-3-O-beta-D-digitaloside.
Impact:
- Expansion of the known chemical diversity of Digitalis lanata.
- Provides novel molecular structures for potential pharmacological investigation.
- Contributes to the field of natural product chemistry and drug discovery from medicinal plants.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...